2024 / 03 / 12

We’re attending at
TIDES ASIA 2024

Ajinomoto Bio-Pharma Services will participate in TIDES ASIA 2024, on March 19 to 21, 2024.

TIDES ASIA is the the only event in Asia exclusively for experts in oligonucleotides, peptides, mRNA, genome editing, and delivery, which is a platform for exchanging strategies to accelerate the process of bringing molecules to market.

At the exhibition booth, a fully integrated CDMO, with sites in Belgium, United States, Japan, and India, providing cGMP manufacturing and drug product of small molecule and large molecule APIs and intermediates.

The latest technologies and services such as AJIPHASE®, AJICAP®, CORYNEX®, and TALAMAX® will be also introduced.

And we will be making the oral presentation about RNA production at the conference.

We look forward to your visit.

Event Name TIDES ASIA 2024
Dates March 19 (Tue) – 20 (Thr), 2024
Venue The Westin Miyako Kyoto
Exhibition Booth 23
Luncheon Presentation
Title and Presenters MNew Ligation Approach: Technology for High Quality Manufacturing of Over 150 mer RNA
Masato Sanosaka Ph.D., Group Leader of Research & Process Development at Ajinomoto Bio-Pharma Services
Abstract It has never been possible to synthesize partially or heavily modified RNA strands that are over 100 mer long with high quality and high yield using continuous solid phase synthesis or in vitro transcription…until now. In this presentation, I will introduce our new synthetic method for producing high-quality long RNA strands through the enzymatic ligation of several short oligonucleotides. At Aji Bio-Pharma, we have successfully produced RNA strands that are over 150 mer long with base modification. Using this method, we have also synthesized protein-encoding mRNA, which are over 500 mer long. Our revolutionary solution enables the synthesis of partially or heavily modified long RNA strands, which were previously unfeasible to produce using earlier methods.
Date, Time and Venue March 20(Wed), 2024 5:00 PM